FDA warns of scramble for workspaces and parking spots in Monday return to office
In Thursday's meeting, the director of the FDA's Center for Drug Evaluation and Research said plans for coming layoffs were ...
KFF Health News on MSN7d
Marty Makary, Often Wrong as Pandemic Critic, Is Poised To Lead the FDA He Railed Against
Should Marty Makary take the reins at the FDA, transitioning from gadfly to the head of an agency that regulates a fifth of ...
NJBIZ9d
FDA alerts NJ pharma over ‘misleading’ cancer drug claims at conference
According to the agency, the 15-year-old company only presented efficacy claims for its branded medication and did not include any warnings or precautions for the tablets at a tradeshow.
FDA warns of scramble for work and parking space in Monday return to office
The U.S. Food and Drug Administration told staff this week it cannot guarantee work space or parking spots among the hurdles they will face on Monday when they return to their offices en mass as ...
Healio2d
How researchers were able to enroll adolescents in landmark HIV trial
Researchers here described how they were able to safely and ethically enroll adolescents in a landmark trial of a drug that ...
Monthly Prescribing Reference9d
FDA Approves Encelto for Macular Telangiectasia Type 2
References: Neurotech’s Encelto™ (revakinagene taroretcel-lwey) approved by the FDA for the treatment of macular telangiectasia type 2 (MacTel). News release Neurotech Pharmaceuticals.
Seres Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
Recent FDA feedback received on SER-155 allogeneic hematopoietic stem cell transplant (allo-HSCT) next study provides support for the proposed ...